Elevated HPRT mutation frequencies in aflatoxin-exposed residents of Daxin, Qidong County, People's Republic of China
Open Access
- 1 November 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 20 (11) , 2181-2184
- https://doi.org/10.1093/carcin/20.11.2181
Abstract
Molecular biomarkers are becoming increasingly important tools to identify people who are at highest risk of developing cancer. For many years we have been studying residents of Qidong County, People's Republic of China, to examine the combined impact of aflatoxin exposure with other risk factors as contributors to the high liver cancer incidence rates in this region. This study was conducted to determine the effects of aflatoxin exposure, as measured by serum aflatoxin–albumin adduct levels, on somatic mutation frequency in the human hypoxanthine guanine phosphoribosyl transferase gene ( HPRT ). Subjects were assigned as low or high according to a dichotomization around the population mean of aflatoxin–albumin adducts. HPRT mutant frequency was determined in individuals by a T cell clonal assay and the samples were categorized as low or high according to mean values. Separate analyses were also conducted for the small set of hepatitis B virus surface antigen (HBsAg)-positive and the larger set of HBsAg-negative individuals, known risk factors for liver cancer. An odds ratio of 19.3 (95% confidence interval 2.0, 183) was demonstrated for a high HPRT mutation frequency in individuals with high aflatoxin exposure compared with those with low aflatoxin exposure. This association indicates that aflatoxin-induced DNA damage in T lymphocytes, assessed using the validated surrogate albumin adduct markers, leads to increased mutations reflected as elevated HPRT gene mutations. This cross-sectional study suggests the potential use of mutation frequency of the HPRT gene as a long-term biomarker of aflatoxin exposure in high risk populations.Keywords
This publication has 24 references indexed in Scilit:
- Carcinogen-DNA and Protein Adducts as Intermediate Biomarkers for Human Chemoprotection TrialsPublished by Springer Nature ,1994
- Role of Aflatoxin–DNA Adducts in the Cancer ProcessPublished by Elsevier ,1994
- Epidemiology of Aflatoxin-Related DiseasePublished by Elsevier ,1994
- Aflatoxin Carcinogenesis in the Context of the Multistage Nature of CancerPublished by Elsevier ,1994
- Molecular biomarkers for human chemical carcinogen exposuresChemical Research in Toxicology, 1993
- Urinary aflatoxin biomarkers and risk of hepatocellular carcinomaThe Lancet, 1992
- Molecular dosimetry of urinary aflatoxin-N7-guanine and serum aflatoxin-albumin adducts predicts chemoprotection by l,2-dithiole-3-thione in ratsCarcinogenesis: Integrative Cancer Research, 1992
- Serum albumin adducts in the molecular epidemiology of aflatoxin carcinogenesis: correlation with aflatoxin B1 intake and urinary excretion of aflatoxin M1Carcinogenesis: Integrative Cancer Research, 1988
- Incidence of Hepato-Carcinoma in Relation to Aflatoxin IntakePublished by Springer Nature ,1980
- Aflatoxin and liver cell cancerTransactions of the Royal Society of Tropical Medicine and Hygiene, 1977